As per MRFR analysis, the US Gastric Bypass Market Size was estimated at 212.34 (USD Million) in 2023. The US Gastric Bypass Market Industry is expected to grow from 250 (USD Million) in 2024 to 550 (USD Million) by 2035.The US Gastric Bypass Market CAGR (growth rate) is expected to be around 7.431% during the forecast period (2025 - 2035).
The US Gastric Bypass Market is experiencing several significant trends shaped by various factors. A primary market driver is the rising prevalence of obesity among the American population, which has led to increased demand for bariatric surgeries as an effective treatment option.
Government health initiatives aimed at reducing obesity-related health problems have also promoted awareness about the benefits of surgical interventions. Additionally, technological advancements in surgical procedures, including minimally invasive techniques, have gained traction, making gastric bypass surgeries safer and more effective; this has resonated well with patients and healthcare providers alike.
There are notable opportunities to be explored within the market. Increased insurance coverage for bariatric procedures, spurred by changes in policy related to obesity management, allows more individuals to consider gastric bypass as a viable option. Furthermore, the development of innovative preoperative and postoperative care programs offers potential for improving patient outcomes, thereby appealing to both healthcare providers and patients looking for comprehensive treatment solutions.
In recent times, trends in the US include a shift towards more personalized treatment plans that cater to the specific needs and health status of patients, reflecting broader movements in healthcare towards tailored treatments. The integration of digital health tools, such as telemedicine and mobile health applications, is enhancing patient engagement and support throughout the weight-loss journey.
This focus on holistic approaches in the US Gastric Bypass Market ensures that patients receive tailored care, improving long-term success rates and overall satisfaction with surgical outcomes.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The United States has seen a dramatic increase in obesity rates over the past few decades, which significantly drives the US Gastric Bypass Market Industry. According to the Centers for Disease Control and Prevention (CDC), the prevalence of obesity among US adults was 42.4% in 2017-2018, an increase from 30.5% in 1999-2000.
This upward trend poses serious health risks, necessitating effective weight loss solutions. The American Society for Metabolic and Bariatric Surgery (ASMBS) indicates that patients suffering from morbid obesity and related comorbidities often turn to surgical interventions, such as gastric bypass, as a more effective and long-term solution compared to lifestyle changes alone.
With the escalating obesity epidemic, more individuals are seeking bariatric surgeries to improve their health, thereby fueling growth in the US Gastric Bypass Market. Furthermore, with over 13 million adults estimated to be eligible for bariatric surgery, the market size is projected to grow significantly as healthcare providers increasingly recommend surgical interventions.
In recent years, there has been a significant increase in awareness and acceptance of bariatric surgery options, including gastric bypass, among US populations. Educational initiatives from organizations like the American Bariatric Surgical Center and the National Institute of Health highlight the benefits and outcomes associated with these procedures, leading to greater public trust.
A recent survey by the ASMBS found that only 30% of severely obese individuals were aware of bariatric surgery as a treatment but this figure is steadily on the rise. Improved awareness is essential as the population becomes more informed about the potential risks and benefits of surgery, thus driving the US Gastric Bypass Market Industry.
Medical technology has witnessed remarkable advancements, particularly in the field of minimally invasive surgical techniques used in gastric bypass procedures. The introduction of new surgical tools and robotic-assisted surgery technologies, endorsed by organizations like the American College of Surgeons, have led to improved patient outcomes, shorter recovery times, and reduced hospital stays.
According to a study published by the Journal of American Medical Association, minimally invasive gastric bypass procedures showcase a 50% reduction in complication rates compared to traditional surgical methods. These advancements are critical in attracting more patients towards surgery as they seek safer and more effective treatment options, thus propelling the growth of the US Gastric Bypass Market.
US government initiatives aimed at decreasing healthcare costs related to obesity and associated diseases also play a crucial role in driving the US Gastric Bypass Market Industry. The Affordable Care Act expanded coverage for bariatric surgery, allowing more individuals to access these life-changing procedures.
A report from the Congressional Budget Office suggests that every dollar spent on bariatric surgery could save approximately $3 in future healthcare costs stemming from obesity-related diseases. As more healthcare plans include bariatric surgery coverage, the rising number of insured patients seeking gastric bypass procedures is expected to significantly bolster market growth.
The US Gastric Bypass Market, categorized by Type, showcases significant segments that contribute to the overall landscape of bariatric surgery. Among these, Endoscopic Sleeve Gastroplasty and Intragastric Balloon have emerged as pivotal procedures.
Endoscopic Sleeve Gastroplasty, a minimally invasive technique, has gained traction owing to its effectiveness and lower complication rates, appealing to patients seeking an alternative to traditional surgical methods. This procedure essentially reshapes the stomach using endoscopic suturing without the need for surgical incisions, thus minimizing recovery time and allowing patients to return to daily activities faster.
Meanwhile, the Intragastric Balloon procedure provides a temporary aid for weight loss by placing a soft balloon in the stomach, creating a feeling of fullness, which supports patients in achieving their weight loss goals without permanent alterations to their anatomy.
These segments collectively contribute to the burgeoning interest in weight loss solutions across the US, echoing the increasing prevalence of obesity within the population. According to recent statistics, nearly 42% of US adults are classified as obese, amplifying the demand for effective weight management solutions, including these procedural types.
The growth drivers for these segments also align with rising healthcare awareness and a greater focus on preventing obesity-related complications, such as diabetes and hypertension. Furthermore, government initiatives to promote healthy living and weight management among citizens continue to bolster the relevance of these interventions.
However, challenges remain, such as patient education regarding procedure options and potential risks associated with each type. Nevertheless, both Endoscopic Sleeve Gastroplasty and Intragastric Balloon represent growing opportunities within the market, as advancements in technology and increasing acceptance of less invasive techniques attract a wider patient demographic.
In summary, the Type segmentation within the US Gastric Bypass Market illustrates a dynamic interplay between innovative procedures and evolving patient needs, paving the way for future developments in the realm of bariatric surgery.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Gastric Bypass Market, focusing on the Indication segment, is shaped by the rising prevalence of various health conditions such as Gastroesophageal Reflux Disease, Heart Disease, and Type 2 Diabetes. Gastric bypass surgery is often performed on patients suffering from these serious health issues as an effective solution for weight management and improving overall health outcomes.
For instance, Gastroesophageal Reflux Disease, characterized by persistent acid reflux, affects millions of Americans, and studies suggest that bariatric surgery significantly alleviates symptoms in such patients, offering a substantial quality-of-life improvement.
Heart Disease remains a leading cause of mortality, and weight loss via gastric bypass can lead to lower risks of heart issues by reducing associated comorbidities. Type 2 Diabetes affects a significant portion of the American population, with numerous studies indicating that gastric bypass contributes to long-term remission in diabetic patients.
These health conditions underscore the importance of the Indication segment, making it a key driver of demand in the US Gastric Bypass Market, ultimately enabling patients to achieve better health and reduce the burden on healthcare systems. The ongoing advancements in surgical techniques and the growing awareness of obesity as a major health crisis add to the opportunities for growth within this sector.
The US Gastric Bypass Market segmentation by End User is significant, particularly highlighting the roles of Hospitals and Surgical Centers. Hospitals serve as the primary point for comprehensive patient care, offering advanced medical technologies and specialized personnel for managing complex cases involving gastric bypass procedures.
Their integration into the healthcare system facilitates a multidisciplinary approach, optimizing patient outcomes and satisfaction. Surgical Centers, on the other hand, focus on efficient delivery of outpatient surgical services. They provide convenience and cost-effectiveness, often leading to quicker recovery times for patients post-operation.
As both End Users adapt to evolving healthcare demands and technological advancements, factors like rising obesity rates in the US bolster their importance. The flexibility of Surgical Centers allows them to accommodate a growing number of procedures, while Hospitals uphold quality standards and ensure extensive follow-up care.
Together, they create a synergistic landscape that supports the US Gastric Bypass Market, driven by the need for accessible and effective treatment options for obesity-related health issues. Trends indicate a steady upward trajectory in procedures performed, reflecting the increasing acceptance and demand for gastric bypass surgery in the population.
The US Gastric Bypass Market is characterized by a dynamic landscape driven by advancements in surgical techniques and emerging technologies aimed at enhancing patient outcomes. This market comprises various stakeholders, including medical device manufacturers, healthcare providers, and surgical centers.
The competition within this sector is intensifying as players strive to innovate and deliver effective treatments for obesity, which has reached epidemic proportions in the United States. The entry of new technologies and a growing emphasis on minimally invasive procedures are reshaping the market dynamics, with companies investing in research and development to capture a larger market share.
As a result, the competitive environment is marked by partnerships, collaborations, and strategic alliances aimed at expanding product offerings and increasing accessibility for patients seeking gastric bypass procedures.
Hologic holds a notable position in the US Gastric Bypass Market, primarily recognized for its advanced medical technology solutions that cater to women's health. With a strong focus on innovative surgical instruments and imaging technologies, Hologic has managed to gain a competitive edge.
The company’s strengths lie in its robust product portfolio that enhances surgical precision and safety during gastric bypass procedures. Hologic's commitment to clinical research and development allows it to refine its offerings continually, promoting better outcomes for patients. Through strategic engagement with healthcare professionals and institutions, Hologic has bolstered its presence in the US market, thus establishing itself as a trusted brand among surgeons and patients alike.
Bariatric Solutions is another important player in the US Gastric Bypass Market, specializing in the provision of treatments and services related to obesity management. The company focuses on delivering innovative bariatric equipment and surgical solutions designed to support both healthcare providers and patients throughout the weight loss journey.
Bariatric Solutions prides itself on its comprehensive service offerings that include not only surgical devices but also patient education and support systems, which are critical for long-term success. The company's strong market presence is reflected in its collaborations with various healthcare institutions, enhancing accessibility to their products.
Additionally, Bariatric Solutions has pursued strategic mergers and acquisitions, enabling it to expand its portfolio and increase its competitiveness in the US market, positioning itself as a reliable partner in addressing the obesity crisis in the region.
The US Gastric Bypass Market has seen significant developments recently, with advances in technology and increased patient accessibility driving growth. Companies like Hologic and Medtronic are focusing on innovative surgical instruments and techniques that enhance patient outcomes.
In June 2023, Johnson and Johnson completed its acquisition of a surgical robotics firm, expanding its expertise in minimally invasive procedures, further pushing the capabilities in this market. In July 2023, Boston Scientific showcased new devices aimed at improving long-term weight loss results, highlighting the competitive landscape.
Additionally, Acelity has been investing in R&D to improve wound management post-surgery, which directly impacts recovery times and patient satisfaction. Market valuation for the Gastric Bypass sector has increased significantly, with a notable uptick in demand for personalized treatment options.
In the previous years, particularly in 2021 and 2022, there was notable growth driven by a nationwide increase in obesity rates, pushing more patients toward surgical options. With continual advancements in surgical techniques and equipment, the market is poised for sustained expansion, emphasizing the importance of adaptive strategies by key players like Ethicon, Stryker, and Intuitive Surgical.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 212.34(USD Million) |
| MARKET SIZE 2024 | 250.0(USD Million) |
| MARKET SIZE 2035 | 550.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.431% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Hologic, Bariatric Solutions, Medtronic, Boston Scientific, Acelity, Conmed, Stryker, Cook Medical, Terumo, Hernia Solutions, Zimmer Biomet, Johnson and Johnson, Ethicon, Reach Surgical, Intuitive Surgical |
| SEGMENTS COVERED | Type, Indication, End User |
| KEY MARKET OPPORTUNITIES | Increasing obesity rates, Technological advancements in procedures, Rising awareness of surgical options, Enhanced patient financing solutions, Growth in telemedicine consultations |
| KEY MARKET DYNAMICS | Increasing obesity rates, Rising healthcare costs, Technological advancements in procedures, Growing awareness and acceptance, Regulatory approvals and guidelines |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Gastric Bypass Market is expected to be valued at 250.0 USD Million in 2024.
By 2035, the US Gastric Bypass Market is projected to reach a value of 550.0 USD Million.
The expected CAGR for the US Gastric Bypass Market from 2025 to 2035 is 7.431%.
The Endoscopic Sleeve Gastroplasty segment is anticipated to dominate the market.
The market value for Endoscopic Sleeve Gastroplasty is expected to be 100.0 USD Million in 2024.
The Intragastric Balloon segment is expected to be valued at 325.0 USD Million in 2035.
Major players in the US Gastric Bypass Market include Hologic, Medtronic, and Johnson & Johnson.
Growing awareness of obesity treatment and technological advancements present significant market growth opportunities.
Regulatory challenges and the high cost of procedures could affect market growth.
The overall growth trend indicates a positive trajectory towards 550.0 USD Million by 2035, driven by increasing demand.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
